{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-042727","form_type":"8-K12G3","ticker":null,"cik":"0002042814","company_name":"Nascent Pharma Holdings, Inc.","filed_at":"2024-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.628069+00:00","generated_at":"2026-05-30T09:51:06.700411+00:00","sec_items":["1.01","3.03","5.03","5.02","5.05","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Nascent Pharma Holdings succeeds Can B Corp. as public holding company via stock-for-stock merger","bullets":["Each share of Can B common and preferred converted 1:1 into equivalent Nascent share; no stockholder vote required.","Outstanding shares: 71,239,311 common, 5 Series A, 1,100 Series C, 4,000 Series D preferred; all classes unchanged.","Same board and officers continue: Marco Alfonsi (CEO), Stanley L. Teeple (CFO, Secretary).","Nascent adopted a Code of Business Conduct and Ethics and an Incentive Stock Option Plan.","New trading symbol not yet assigned; FINRA processing pending."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-042727","json":"https://secwatch.observer/filing/0001493152-24-042727.json","markdown":"https://secwatch.observer/filing/0001493152-24-042727.md","text":"https://secwatch.observer/filing/0001493152-24-042727.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2042814/000149315224042727/0001493152-24-042727-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2042814/000149315224042727/form8-k12g3.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T09:51:06.700411+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"46627610307c6862a05f67d563b24b8b2ca21282","claim":"Nascent Pharma Holdings, Inc.: Adopted new Articles of Incorporation substantially identical to prior Can B articles except for name change (effective 2024-09-13).","evidence_excerpt":"The Nascent Articles of Incorporation were filed with the Florida Secretary of State on September 13, 2024.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/2042814/000149315224042727/0001493152-24-042727-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-09-13"}],"fact_type":"governance_change"},{"claim_id":"70ccf9aca57f4542fd369a99680dc78a24b7c856","claim":"Nascent Pharma Holdings, Inc.: Adopted new Bylaws substantially identical to prior Can B bylaws except for name change.","evidence_excerpt":"adopted the Bylaws of Nascent (the “ Nascent Bylaws ”) that each contains provisions substantially identical to those of Can B immediately prior to the consummation of the Nascent Merger, except for the change of the name of the corporation","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/2042814/000149315224042727/0001493152-24-042727-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"}],"fact_type":"governance_change"},{"claim_id":"afe162530f032a66be373999dfe3bc3359723ac5","claim":"Nascent Pharma Holdings, Inc.: Adopted a Code of Business Conduct and Ethics (effective 2024-10-24).","evidence_excerpt":"On October 24, 2024, Nascent adopted a Code of Business Conduct and Ethics (the “ Code ”) that was approved by the Board of Directors on October 25, 2024","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/2042814/000149315224042727/0001493152-24-042727-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"code of ethics"},{"label":"Effective","value":"2024-10-24"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}